139 related articles for article (PubMed ID: 36902191)
21. A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.
Nishikawa H; Nishijima N; Enomoto H; Sakamoto A; Nasu A; Komekado H; Nishimura T; Kita R; Kimura T; Iijima H; Nishiguchi S; Osaki Y
Medicine (Baltimore); 2016 Sep; 95(36):e4832. PubMed ID: 27603400
[TBL] [Abstract][Full Text] [Related]
22. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
23. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J
J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655
[TBL] [Abstract][Full Text] [Related]
24. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.
Shoji B; Ikeda F; Fujioka S; Kobashi H; Yasunaka T; Miyake Y; Shiraha H; Takaki A; Nouso K; Iwasaki Y; Yamamoto K
J Gastroenterol; 2010 Nov; 45(11):1172-82. PubMed ID: 20549250
[TBL] [Abstract][Full Text] [Related]
26. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
27. The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.
Abu-Amara M; Cerocchi O; Malhi G; Sharma S; Yim C; Shah H; Wong DK; Janssen HL; Feld JJ
Gut; 2016 Aug; 65(8):1347-58. PubMed ID: 25934760
[TBL] [Abstract][Full Text] [Related]
28. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment.
Gokcen P; Guzelbulut F; Adali G; Degirmenci Salturk AG; Ozturk O; Bahadir O; Kanatsiz E; Kiyak M; Ozdil K; Doganay HL
World J Gastroenterol; 2022 Feb; 28(6):665-674. PubMed ID: 35317422
[TBL] [Abstract][Full Text] [Related]
29. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.
Yang HI; Yuen MF; Chan HL; Han KH; Chen PJ; Kim DY; Ahn SH; Chen CJ; Wong VW; Seto WK;
Lancet Oncol; 2011 Jun; 12(6):568-74. PubMed ID: 21497551
[TBL] [Abstract][Full Text] [Related]
30. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
31. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yang H; Bae SH; Nam H; Lee HL; Lee SW; Yoo SH; Song MJ; Kwon JH; Nam SW; Choi JY; Yoon SK; Jang JW
J Hepatol; 2022 Sep; 77(3):632-641. PubMed ID: 35398462
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
33. A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements.
Lin YJ; Chang CL; Chen LC; Hu HH; Liu J; Korenaga M; Huang YH; Jen CL; Su CY; Nishida N; Sugiyama M; Lu SN; Wang LY; Yuan Y; L'Italien G; Yang HI; Mizokami M; Chen CJ; Lee MH
Clin Transl Gastroenterol; 2018 Sep; 9(9):183. PubMed ID: 30237482
[TBL] [Abstract][Full Text] [Related]
34. Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease.
Hashem S; ElHefnawi M; Habashy S; El-Adawy M; Esmat G; Elakel W; Abdelazziz AO; Nabeel MM; Abdelmaksoud AH; Elbaz TM; Shousha HI
Comput Methods Programs Biomed; 2020 Nov; 196():105551. PubMed ID: 32580053
[TBL] [Abstract][Full Text] [Related]
35. Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir.
Kim MN; Hwang SG; Rim KS; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SU
Liver Int; 2017 Dec; 37(12):1788-1795. PubMed ID: 28418595
[TBL] [Abstract][Full Text] [Related]
36. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
37. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
38. Expression of Ku86 and presence of Ku86 antibody as biomarkers of hepatitis B virus related hepatocellular carcinoma.
Xu Y; Liu AJ; Gao YX; Hu MG; Zhao GD; Zhao ZM; Liu R
Dig Dis Sci; 2014 Mar; 59(3):614-22. PubMed ID: 24271118
[TBL] [Abstract][Full Text] [Related]
39. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.
Sahin T; Serin A; Emek E; Bozkurt B; Arikan BT; Tokat Y
Transplant Proc; 2019 Sep; 51(7):2397-2402. PubMed ID: 31402255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
